Skip to content
Search AI Powered

Latest Stories

GPhC in final stages to declare registration assessment date

The GPhC has said on Tuesday (September 22) that it is in the final stages of the procurement exercise to announce the date of this year’s postponed registration assessment.

The General Pharmaceutical Council (GPhC) further clarified that it will provide further updates on the assessment to all the candidates by the end of this month.


The regulator’s latest update on the registration assessment date follows the joint letter from the British Pharmaceutical Students’ Association (BPSA) and the Royal Pharmaceutical Society (RPS) which urged the GPhC to announce the date of the postponed 2020 registration assessment without delay.

In a response to joint letter, Nigel Clarke, Chair of the GPhC, said: “We want to give candidates clarity about the date of the assessment as soon as possible but cannot confirm an exact date until we have completed the procurement exercise to identify a supplier to provide the online assessment.

“We are now in the very final stages of the procurement exercise and expect to be able to give a further update to all candidates by next week. Once the supplier has been appointed, we will work with them at pace to identify when the registration assessment can be held.

“This is the first time we have held an online assessment and it is a very complex process to move the assessment online. We want to make sure that the new online platform supports all candidates, including those who may need adjustments, to complete the assessment to the best of their abilities.”

Commenting on the response from the regulator, Paul Bennett, RPS Chief Executive, said: “We appreciate this rapid response from the GPhC and are encouraged that they have taken our concerns onboard.  RPS and BPSA will support the GPhC and its trainees in any way we can.”

Regan McCahill, BPSA President, said: ““It is vital that provisionally registered pharmacists, and those who were ineligible for the provisional register, get the answers they need about arrangements for the assessment.

“The prolonged uncertainty and the likelihood that the delay will extend into 2021 is deeply troubling. We very much want to see the GPhC address this as a matter of urgency and would also expect them to communicate more regularly and openly with trainees.”

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less